Cape Investment Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
3,955
-510
-11% -$189K 0.41% 46
2026
Q1
$1.31M Buy
4,465
+435
+11% +$143K 0.43% 50
2025
Q4
$1.41M Buy
4,030
+102
+3% +$34.5K 0.43% 45
2025
Q3
$1.27M Sell
3,928
-29
-0.7% -$9.02K 1.25% 15
2025
Q2
$1.54M Buy
3,957
+163
+4% +$65.6K 0.56% 39
2025
Q1
$1.65M Sell
3,794
-50
-1% -$20.1K 0.66% 34
2024
Q4
$1.42M Buy
3,844
+948
+33% +$397K 0.55% 40
2024
Q3
$1.51M Buy
2,896
+35
+1% +$18.7K 0.61% 39
2024
Q2
$1.55M Buy
2,861
+13
+0.5% +$6.87K 0.7% 34
2024
Q1
$1.48M Buy
2,848
+27
+1% +$13.4K 0.69% 33
2023
Q4
$1.33M Buy
2,821
+56
+2% +$25.9K 0.65% 31
2023
Q3
$1.2M Buy
2,765
+97
+4% +$44K 0.68% 31
2023
Q2
$1.19M Buy
2,668
+356
+15% +$164K 0.66% 35
2023
Q1
$1.06M Buy
+2,312
New +$1.1M 0.65% 34

Other funds holding ELV

Cape Investment Advisory's ELV Position: Q2 2026 in Review

Cape Investment Advisory reduced its Elevance Health (ELV) stake by 11% in Q2 2026, selling an estimated $189K and leaving 3,955 shares worth $1.53M. The position accounts for 0.41% of the portfolio, ranked #46.

Cape Investment Advisory first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.65M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cape Investment Advisory held 3,955 shares of Elevance Health worth $1.53M as of Q2 2026.
  • Cape Investment Advisory sold 510 Elevance Health shares in Q2 2026, an estimated $189K.
  • Elevance Health made up 0.41% of Cape Investment Advisory's portfolio in Q2 2026, its #46 holding.
  • Cape Investment Advisory first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Cape Investment Advisory's Elevance Health position peaked at $1.65M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.